Rosetta Genomics Posts Q4 Revenues Following Product Launches | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics today reported fourth-quarter revenues of $119,000 compared to no revenues for the fourth quarter of 2008.

The Israel-based microRNA molecular diagnostics maker launched its first three tests late in 2009 — the miRview mets, miRview meso and miRview squamous tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.